Latest News and Press Releases
Want to stay updated on the latest news?
Search Results
Everything
-
NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- With the colder months on the horizon, millions across the country are bracing for the annual cold and flu season. As coughs, sneezes, and fevers become...
-
September 10, 2024 12:21 ET | Source: Risk Less. Do More. Pan Respiratory Virus Public Education Campaign
Milwaukee, Wis., Sept. 10, 2024 (GLOBE NEWSWIRE) -- The U.S. Department of Health and Human Services’ (HHS) Risk Less. Do More. campaign is partnering with the HBCU Tailgate Tour to increase...
-
Combining FluGen's M2SR nasal spray flu vaccine with Sanofi's Fluzone High Dose shot generates superior results in older adults versus the shot alone.
-
Unity Consortium marks Adolescent Immunization Action Week, April 1-5, 2024, encouraging parents and adolescents to get up to date on recommended vaccines
-
Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate
-
JUPITER, Fla., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
-
Dyadic to Present at Industry and Investor Events in October
-
SAN FRANCISCO, July 20, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Phase 2 PENINSULA (PrevEntioN of IllNesS DUe to InfLuenza A) trial evaluating VIR-2482...
-
Lab-quality results for both COVID-19 and Flu now available at home from one single testCOVID-19 and Flu have similar symptoms but different treatments, requiring a fast, differential test to access...
-
MIAMI, March 03, 2023 (GLOBE NEWSWIRE) -- eMed, the leader in at-home, test-to-treat telehealth kits, today announced the first-of-its-kind eMed® Urgent Care Telehealth Kit™. Powered by eMed's...